CS logo
small CS logo
Izmir Medical Park Hospital - Medical Oncology

Izmir, Turkey
General hospital in İzmir
İmbatlı, Yeni Girne Bulvarı, 1825. Sk. No - 12, 35575 Karşıyaka/İzmir

About Izmir Medical Park Hospital - Medical Oncology


"İEÜ Medical Park Hastanesi, tüm branşların yanı sıra Onkoloji, Kemik İliği ve Organ Nakli ve Mikro-cerrahi alanlarında ön plana çıkıyor. Erişkin ve pediatrik kemik iliği, karaciğer, böbrek, pankreas, ince bağırsak, kalp, akciğer nakli gibi tüm organ nakli alanlarında Türkiye'de komple çözüm getiren bir organ nakli merkezi olmayı, nakil merkezimizle Dünyada organ nakli yapan hastaneler arasında referans olmayı, PET-CT ve LINAC cihazlarımızla Ege Bölgesi'nde onkoloji alanında da geniş bir hizmet yelpazesi sunmayı, Gamma-Knife teknolojisini Ege Bölgesi'ne getirmeyi amaçlıyor."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Izmir Medical Park Hospital - Medical Oncology


During the past decade, Izmir Medical Park Hospital - Medical Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Izmir Medical Park Hospital - Medical Oncology


According to Clinical.Site data, the most researched conditions in "Izmir Medical Park Hospital - Medical Oncology" are "Non-Small Cell Lung Cancer" (1 trials) and "Squamous Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Izmir Medical Park Hospital - Medical Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Izmir Medical Park Hospital - Medical Oncology


Most popular intervention types in "Izmir Medical Park Hospital - Medical Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Gefitinib 250 mg" (1 trials), "Gefitinib-matching placebo 250 mg" (1 trials), "HLX10" (1 trials), "Lazertinib 240 mg/160 mg" (1 trials) and "Lazertinib-matching placebo 240 mg/160 mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Izmir Medical Park Hospital - Medical Oncology


The vast majority of trials in "Izmir Medical Park Hospital - Medical Oncology" are 2 trials for "All" genders.

Clinical Trials Status at Izmir Medical Park Hospital - Medical Oncology


Currently, there are NaN active trials in "Izmir Medical Park Hospital - Medical Oncology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Izmir Medical Park Hospital - Medical Oncology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Izmir Medical Park Hospital - Medical Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".